BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe Weather

MENLO PARK, Calif., March 20, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it has cancelled its presentation at Oppenheimer's 28^th Annual Healthcare Conference in New York tomorrow, due to the winter storm warnings forecasted for the region.  BioPharmX President and Co-founder Anja Krammer had been scheduled to speak.

The corporate presentation may be downloaded from the Overview section of the company's Investors web page: http://biopharmx.investorroom.com.

About BioPharmX^® Corporation
BioPharmX Corporation (NYSE American: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.

BioPharmX is a registered trademark of BioPharmX, Inc.

SOURCE BioPharmX Corporation

Related Links

http://www.biopharmx.com